Rights and permissions
About this article
Cite this article
Third-line agents cost saving in chronic bronchitis. Pharmacoecon. Outcomes News 210, 8 (1999). https://doi.org/10.1007/BF03274959
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03274959